RIVAC Borrelia
RIVAC Borrelia
Authorised
- Borreliella garinii, Inactivated
Product identification
Medicine name:
RIVAC Borrelia
Active substance:
- Borreliella garinii, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Borreliella garinii, Inactivated1.00/relative unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- PEI.V.02827.01.1
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/02/2022
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 6/02/2024
How useful was this page?:
